Crossover Clinical Trials in Colombia

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Crossover Clinical Trials in Colombia

Crossover Clinical Trials in Colombia – Clinical Landscape in LATAM

Colombia, known for its rich biodiversity and cultural heritage, has also emerged as a prominent player in the global healthcare landscape. As the country continues to strengthen its healthcare infrastructure and scientific capabilities, it has become a key participant in advancing medical research.

Among the various innovative trial designs utilized, crossover clinical trials have gained significant attention. In this blog, we explore the significance of crossover trials in Colombia’s medical research scene, their potential benefits, challenges, and their contribution to the advancement of medical knowledge.

Understanding Crossover Clinical Trials:

Crossover clinical trials are a unique and powerful research design that involves participants receiving multiple treatments in sequence. Each participant acts as their control, receiving different treatments at different points during the study. This design ensures that each subject serves as both a treatment group and a control group, increasing the efficiency and statistical power of the study. To avoid carryover effects, there is a washout period between each treatment phase.

Significance in the Colombian Medical Research Landscape:

Colombia’s active involvement in crossover clinical trials reflects the country’s commitment to advancing medical science and improving patient outcomes. Several factors contribute to the significance of crossover trials in Colombia:

a) Diverse Patient Population: Colombia’s population is ethnically and genetically diverse, making it an ideal setting for crossover trials. Researchers can analyze treatment responses in various subpopulations, leading to more comprehensive and generalizable results.

b) Cost-Effectiveness: Crossover trials offer an efficient use of resources by assessing multiple treatments in a single study, reducing costs, and shortening the trial duration.

c) Tailored Treatment Approaches: Individualized treatment plans in crossover trials can lead to improved patient outcomes, especially in chronic diseases where personalized therapies are crucial.

Challenges and Mitigation Strategies:

While crossover trials offer numerous advantages, they also present specific challenges that researchers in Colombia are actively addressing:

a) Carryover Effects: To minimize the risk of carryover effects from previous treatments, researchers carefully design the washout period, allowing sufficient time for the previous treatment to leave the system.

b) Patient Compliance: Maintaining patient compliance throughout the study is essential for the trial’s integrity. Researchers employ various strategies, such as education and regular follow-ups, to ensure participants adhere to the treatment regimen.

c) Ethical Considerations: Obtaining informed consent from participants in crossover trials can be complex due to multiple treatment phases. Researchers prioritize transparency and comprehensive communication to address ethical concerns effectively.

Crossover Clinical Trials in Colombia

Crossover Clinical Trials in Colombia

Crossover Clinical Trials in Colombia

Real-World Applications:

Crossover clinical trials in Colombia have made significant contributions to various medical fields, resulting in groundbreaking discoveries and treatment advancements:

a) Chronic Disease Management: In the context of chronic diseases like diabetes or cardiovascular conditions, crossover trials have evaluated the efficacy of different medications and lifestyle interventions, leading to improved management strategies.

b) Drug Development: Pharmaceutical companies conduct crossover trials to evaluate the effectiveness and safety of new drugs, potentially accelerating their approval process and bringing novel treatments to patients faster.

c) Nutritional Studies: Colombia’s diverse culinary traditions have also provided an ideal backdrop for crossover trials investigating the impact of dietary interventions on health outcomes.

Collaboration and Future Prospects:

The success of crossover clinical trials in Colombia has been bolstered by collaborative efforts among academia, healthcare institutions, and the government. By fostering these partnerships and encouraging international collaboration, Colombia can continue to position itself as a leader in medical research, making meaningful contributions to global healthcare knowledge.


Crossover clinical trials have emerged as a crucial tool in Colombia’s pursuit of scientific excellence and improved patient care. With its diverse patient population and dedication to ethical research practices, Colombia stands at the forefront of medical advancements.

By harnessing the power of crossover trials and fostering collaborative initiatives, the nation is poised to shape a brighter future for healthcare, not only within its borders but also on the global stage.

Crossover Clinical Trials in Colombia

Source: Pro Colombia

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Crossover Clinical Trials in Colombia

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Crossover Clinical Trials in Colombia

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Crossover Clinical Trials in Colombia

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Crossover Clinical Trials in Colombia

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Crossover Clinical Trials in Colombia

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Crossover Clinical Trials in Colombia

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Crossover Clinical Trials in Colombia

The Cohortias Team

Crossover Clinical Trials in Colombia

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Crossover Clinical Trials in Colombia

Network & Partnerships